Columbia University

Northwestern University

Saktimayee Mitra Roy

Ottavio Arancio

Jeffrey Claude Pelletier

Daniel Martin Watterson

The invention provides for novel MAP kinase inhibitors and compositions comprising the same. In some embodiments, the MAP kinase inhibitors are p38&#x3b1; MAP kinase inhibitors. The invention further provides for methods for treatment of diseases comprising administration of MAP kinase inhibitors or compositions comprising MAP kinase inhibitors. In some embodiments, the disease is Alzheimer's Disease, ALS, Huntington's Disease or Parkinson's Disease.

Growing community of inventors

Evanston, IL, United States of America

Saktimayee Mitra Roy